Efficacy and Safety of Acetaminophen in Postoperative Pain Management of Infants
1 other identifier
interventional
220
1 country
1
Brief Summary
Pain will bring early and long-term adverse reactions to infants. The investigators need to pay attention to whether there is pain in infants after surgery. Since infants cannot self-report pain,The investigators need to use appropriate pain assessment scale to evaluate the pain of these infants, so as to understand the status of postoperative pain in children. The result of pain score not only enables investigators to understand the pain status of children, but also helps investigators to give corresponding intervention and treatment according to the pain degree of children. Postoperative pain management is one of the core contents of ERAS. Effective pain management is beneficial to the early postoperative recovery of infants and reduces the adverse reactions caused by pain. Sveral studies have confirmed that the combination of acetaminophen and opioids could reduce the use of opioids after surgery. But even if opioid use is reduced, it still causes many side effects for children. This study evaluated the safety and efficacy of acetaminophen alone for postoperative analgesia in infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2022
CompletedFirst Submitted
Initial submission to the registry
September 16, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedJuly 10, 2024
July 1, 2024
8 months
September 16, 2022
July 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Using CRIES scale to assess the pain level at 12 hours after postoperative awakening
The pain score was evaluated 12 hours after Children wake up
12 hours after postoperative awakening
Secondary Outcomes (23)
liver function
48 hours after surgery
renal function
48 hours after surgery
LOS
30 days after surgery
Using CRIES scale to assess the pain level at 1 hour after postoperative awakening
1 hour after postoperative awakening
Using CRIES scale to assess the pain level at 6 hours after postoperative awakening
6 hours after postoperative awakening
- +18 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALAfter recovering and returning to the ward, acetaminophen (10mg/kg) was taken orally immediately; once every 6 hours, a total of 4 times.
placebo group
PLACEBO COMPARATORThe same amount of sterilized water was administered orally at the same time points.
Interventions
When the infants woke up after surgery and were transported back to the ward, they were randomly divided into two groups immediately. The intervention group was given oral acetaminophen, once every 6 hours, for a total of 4 times.
When the infants woke up after surgery and were transported back to the ward, they were randomly divided into two groups immediately. The control group was given sterilized water, once every 6 hours, for a total of 4 times.
Eligibility Criteria
You may qualify if:
- Informed consent was obtained from parents of children;
- Infants aged 0-12 months;
- Children who underwent abdominal and perineal surgery in the Department of Neonatal Surgery, Children's Hospital Affiliated to Nanjing Medical University and returned to the unaccompanied ward after removal of tracheal intubation.
You may not qualify if:
- No informed consent was obtained from parents;
- known allergy or intolerance to acetaminophen;
- Children with liver function impairment (alanine aminotransferase/aspartate aminotransferase (ALAT/ASAT) more than three times the reference value;
- Children with renal insufficiency (urea and creatinine values exceeding the upper limit of reference values);
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210008, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Department of neonatal surgery
Study Record Dates
First Submitted
September 16, 2022
First Posted
October 4, 2022
Study Start
September 14, 2022
Primary Completion
May 15, 2023
Study Completion
July 31, 2023
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share